China BlueChemical (CBLUY)
(Delayed Data from OTC)
$11.19 USD
0 (0.00%)
Updated Dec 31, 1969 06:00 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for China BlueChemical Ltd falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,835 | 2,122 | 2,077 | 1,510 | 1,571 |
Cost Of Goods | 1,544 | 1,745 | 1,622 | 1,279 | 1,293 |
Gross Profit | 291 | 377 | 455 | 231 | 278 |
Selling & Adminstrative & Depr. & Amort Expenses | 89 | 87 | 74 | 101 | 106 |
Income After Depreciation & Amortization | 203 | 289 | 381 | 130 | 172 |
Non-Operating Income | 179 | 52 | 36 | 34 | 42 |
Interest Expense | 5 | 4 | 8 | 11 | 15 |
Pretax Income | 376 | 337 | 409 | 153 | 200 |
Income Taxes | 41 | 70 | 155 | 40 | 90 |
Minority Interest | -1 | 23 | 22 | 5 | 7 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 335 | 267 | 254 | 113 | 109 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 337 | 244 | 232 | 108 | 102 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 291 | 374 | 468 | 224 | 274 |
Depreciation & Amortization (Cash Flow) | 89 | 84 | 86 | 94 | 102 |
Income After Depreciation & Amortization | 203 | 289 | 381 | 130 | 172 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 91.60 | 92.20 | 93.60 | NA | 93.76 |
Diluted EPS Before Non-Recurring Items | 3.68 | 2.67 | 2.48 | NA | 1.00 |
Diluted Net EPS (GAAP) | 3.68 | 2.68 | 2.48 | 1.16 | 1.09 |
Fiscal Year end for China BlueChemical Ltd falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -99,999.00 | -99,999.00 | NA | NA | NA |
Diluted Net EPS (GAAP) | -99,999.00 | -99,999.00 | NA | NA | NA |